Paul Tudor Jones Imara Inc. Transaction History

Tudor Investment Corp Et Al

  • $26.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$1.11 - $2.42 $30,402 - $66,283
-27,390 Reduced 52.78%
24,502 $56,000
Q2 2022

Aug 15, 2022
SELL
$0.99 - $1.87 $30 - $57
-31 Reduced 0.06%
51,892 $63,000
Q3 2021

Nov 15, 2021
BUY
$4.08 - $7.83 $211,845 - $406,557
51,923 New
51,923 $212,000

Others Institutions Holding IMRA

# of Institutions
3
Shares Held
104K
Call Options Held
0
Put Options Held
170K
View Full List

About IMARA Inc.

IMRA Quotes by TradingView
  • Ticker IMRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,287,300
  • Market Cap $552M
  • Description
  • IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...
More about IMRA
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email